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Abstract 
Review on t(2;3)(p16;q26) BCL11A/MECOM, 
with data on clinics, and the genes implicated. 
Identity 
Note 
This translocation is found in a subset of cases 
described in the card t(2;3)(p15-23;q26-27).  
Other subsets involve other genes, such as THADA 
in the t(2;3)(p21;q26) THADA/MECOM. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML) 
Phenotype/cell stem origin 
There were one M1-AML, two M2-AMLs, and one 
M5-AML; patients presented with dysplasia of at 
least two myeloid cell lineages. 
Epidemiology 
Four cases to date; there were three male and one 
female patients; patients were aged 36, 36, 36, and 
55 (in years) (Trubia et al., 2006). 
Prognosis 
Clinical outcome in cases with the t(2;3)(p16;q26) 
BCL11A/MECOM and the case with the 
t(2;3)(p21;q26) THADA/MECOM (plotted 
together) was severe: "One patient is alive with 
active disease at 12 months, five patients died after 





MECOM was overexpressed. 
Cytogenetics 
Cytogenetics morphological 
The t(2;3)(p16;q26) was the sole anomaly in two of 
four cases (at least in a subclone), accompanied 
with -7 in one case, and +14 in another case. 






BCL11A is a Krüppel zinc-finger transcription 
factor, which has been shown to be essential for 
pre-B-cell development, thymocyte maturation, and 
globin switching, expressed in haematopoietic and 
neural tissues. BCL11A controls FLT3 and IL7R 
expression in early hematopoietic progenitors (Wu 





MECOM is also known as EVI1 or PRDM3; 
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Protein 
"EVI1" contains two domains of seven and three 
zinc finger motifs, respectively, a repression 
domain between the two sets of zinc fingers, and an 
acidic domain at its C-term. Sequence specific 
DNA binding protein.  
Interacts with transcriptional coactivators, 
corepressors, and other sequence specific 
transcription factors. MECOM ("MDS1-EVI1") 
also contains a PR domain from "MDS1" in N-term 
(Wieser, 2008). 








The t(2;3) brings about the juxtaposition at 3q26 of 
the MECOM locus with regulatory elements  
normally located in proximity of the 2p 
breakpoints, with consequent EVI1 overexpression, 
without the formation of a fusion protein. 
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